Amgen estimates its U.S. tax bill at over $6 billion as it repatriates cash

NEW YORK (Reuters) - Amgen Inc said it expects to incur tax expenses of $6 billion to $6.5 billion over time as it repatriates cash it has accumulated around the world because of the new U.S. tax law signed by President Donald Trump on Friday.

Amgen estimates its U.S. tax bill at over $6 billion as it repatriates cash
Read More


Bagikan Berita Ini